Safety and Feasibility of [177Lu] Lu-PSMA Therapy in Glioblastoma
This study demonstrated that [ 177 Lu] Lu-PSMA therapy could be a safe and potentially effective salvage therapy in the progressive/persistent GBM and should be more evaluated with further dedicated study to assess more precise selection criteria and therapeutic protocol and timing.
Authors
- Tahereh Ghaedian (ORCID: https://orcid.org/0000-0003-1216-6609)
- Nahid Masoudi (ORCID: https://orcid.org/0000-0002-0237-7747)
- Abdolmajid Alipour (ORCID: https://orcid.org/0000-0002-0427-969X)
- Abbas Rakhsha (ORCID: https://orcid.org/0000-0001-9561-9874)
- Mehrnaz Ghaedian (ORCID: https://orcid.org/0000-0002-0054-4337)
- Hamid Nasrollahi (ORCID: https://orcid.org/0000-0002-7423-3312)
- Babak Yazdani
- Mohammad Atefi
- Zahra Shabani
Institutions
- Shiraz University of Medical Sciences (IR)
- Namazi Hospital (IR)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1097/rlu.0000000000006219
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00